C3 glomerulopathy — understanding a rare complement-driven renal disease

Richard J. Smith; Gerald B. Appel; Anna M. Blom; H. Terence Cook; Vivette D. D’Agati; Fádi Fakhouri; Véronique Frémeaux‐Bacchi; Mihály Józsi; David Kavanagh; John D. Lambris; Marina Noris; Matthew C. Pickering; Giuseppe Remuzzi; Santiago Rodrı́guez de Córdoba; Sanjeev Sethi; Johan van der Vlag; Peter F. Zipfel; Carla Nester

doi:10.1038/s41581-018-0107-2

Article2022

Therapeutic Small Interfering RNA Targeting Complement C3 in a Mouse Model of C3 Glomerulopathy

Cristina Zanchi, Monica Locatelli, Domenico Cerullo, Verena Aumiller, Daniela Corna, Daniela Rottoli, Mona Eisermann, Roberta Donadelli, Mansoureh Mousavi, Marina Noris, Giuseppe Remuzzi, Ariela Benigni, Carla Zoja

Dataset

Dataset related to: Therapeutic Small Interfering RNA Targeting Complement C3 in a Mouse Model of C3 Glomerulopathy

Cristina Zanchi, Monica Locatelli, Domenico Cerullo, Verena Aumiller, Daniela Corna, Daniela Rottoli, Mona Eisermann, Roberta Donadelli, Mansoureh Mousavi, Marina Noris, Giuseppe Remuzzi, Ariela Benigni, Carla Zoja

Dataset

Dataset related to: Therapeutic Small Interfering RNA Targeting Complement C3 in a Mouse Model of C3 Glomerulopathy

Cristina Zanchi, Monica Locatelli, Domenico Cerullo, Verena Aumiller, Daniela Corna, Daniela Rottoli, Mona Eisermann, Roberta Donadelli, Mansoureh Mousavi, Marina Noris, Giuseppe Remuzzi, Ariela Benigni, Carla Zoja

Article2018

Statistical Validation of Rare Complement Variants Provides Insights into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy

Amy J. Osborne, Matteo Breno, Nicolò Ghiringhelli Borsa, Fengxiao Bu, Véronique Frémeaux‐Bacchi, Daniel P. Gale, Lambertus P. van den Heuvel, David Kavanagh, Marina Noris, Sheila Pinto, Pavithra M. Rallapalli, Giuseppe Remuzzi, Santiago Rodrı́guez de Córdoba, Ángela Ruiz, Richard J. Smith, Paula Vieira‐Martins, Elena B. Volokhina, Valerie Wilson, Timothy H.J. Goodship, Stephen J. Perkins

Article2016

Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome

Paraskevas Iatropoulos, Marina Noris, Caterina Mele, Rossella Piras, Elisabetta Valoti, Elena Bresin, Manuela Curreri, Elena Mondo, Anna Zito, Sara Gamba, Serena Bettoni, Luisa Murer, Véronique Frémeaux‐Bacchi, Marina Vivarelli, Francesco Emma, Erica Daina, Giuseppe Remuzzi

C3 glomerulopathy — understanding a rare complement-driven renal disease

Discussion(0)

Related publications

Therapeutic Small Interfering RNA Targeting Complement C3 in a Mouse Model of C3 Glomerulopathy

Dataset related to: Therapeutic Small Interfering RNA Targeting Complement C3 in a Mouse Model of C3 Glomerulopathy

Dataset related to: Therapeutic Small Interfering RNA Targeting Complement C3 in a Mouse Model of C3 Glomerulopathy

Statistical Validation of Rare Complement Variants Provides Insights into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy

Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome